Cook Medical Issues Global Recall Of Beacon Tip Angiographic Catheter Products

On July 2, 2015, Cook Medical initiated a lot-specific voluntary recall of 2,239 lots of Beacon Tip Angiographic Catheters. Globally, 95,167 devices are subject to this recall. The products include specific versions and lot numbers of the Torcon NB® Advantage Beacon® Tip Catheters (Catalog Prefix HNBR5.0), Royal Flush® Plus Beacon® Tip High-Flow Catheters (Catalog Prefix HNR4.0), and Slip-Cath® Beacon® Tip Catheters (Catalog Prefix SCBR5.0).

The Kraft Heinz Company Voluntarily Recalls Select Varieties of Kraft Singles Products Due to Potential Choking Hazard

The Kraft Heinz Company is voluntarily recalling select code dates and manufacturing codes of Kraft Singles individually-wrapped slices due to the possibility that a thin strip of the individual packaging film may remain adhered to the slice after the wrapper has been removed. If the film sticks to the slice and is not removed, it could potentially cause a choking hazard.

Kilwin’s Quality Confections, Inc. Issues Allergy Alert on Undeclared Cashew in Sugar Free Milk Chocolate Caramels

Kilwin’s Quality Confections, Inc., of Petoskey, Michigan, is voluntarily recalling 5 ounce containers of SUGAR FREE Milk Chocolate Caramels because they were incorrectly labeled and may contain undeclared cashew. People who have an allergy or severe sensitivity to cashew run the risk of serious or life-threatening allergic reaction if they consume these incorrectly labeled products.

Baxter Initiates Voluntary Nationwide Recall Of One Lot Of Iv Solution Due To The Potential For Leaking Containers, Particulate Matter And Missing Port Protectors

DEERFIELD, Ill., July 30, 2015 – Baxter International Inc. announced today it is voluntarily recalling one lot of intravenous (IV) solution to the hospital/user level due to the potential for leaking containers, particulate matter and missing port protectors. Baxter was made aware of these issues through customer complaints.

FDA approves non-surgical temporary balloon device to treat obesity

The U.S. Food and Drug Administration today approved a new balloon device to treat obesity without the need for invasive surgery. The ReShape Integrated Dual Balloon System (ReShape Dual Balloon) is intended to facilitate weight loss in obese adult patients. The device likely works by occupying space in the stomach, which may trigger feelings of fullness, or by other mechanisms that are not yet understood.

FDA approves non-surgical temporary balloon device to treat obesity

The U.S. Food and Drug Administration today approved a new balloon device to treat obesity without the need for invasive surgery. The ReShape Integrated Dual Balloon System (ReShape Dual Balloon) is intended to facilitate weight loss in obese adult patients. The device likely works by occupying space in the stomach, which may trigger feelings of fullness, or by other mechanisms that are not yet understood.